Arcturus Therapeutics Holdings (ARCT) Enterprise Value Growth (3y) (2021 - 2026)
Arcturus Therapeutics Holdings (ARCT) Enterprise Value Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.03 Bn | 467.24 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.09 Bn | 114.84 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.01 Bn | 61.26 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.99 Bn | 50.80 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Arcturus Therapeutics Holdings | 163.56 Mn | -47.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.62% |
| Dec 31, 2025 | 16.16% |
| Sep 30, 2025 | 0.33% |
| Jun 30, 2025 | 3.92% |
| Mar 31, 2025 | 7.20% |
| Dec 31, 2024 | 1.98% |
| Sep 30, 2024 | 10.96% |
| Jun 30, 2024 | 10.07% |
| Mar 31, 2024 | 9.73% |
| Dec 31, 2023 | 9.16% |
| Sep 30, 2023 | -0.53% |
| Jun 30, 2023 | -33.45% |
| Mar 31, 2023 | -76.67% |
| Dec 31, 2022 | -76.43% |
| Sep 30, 2022 | -47.43% |
| Jun 30, 2022 | -71.87% |
| Mar 31, 2022 | -117.15% |
| Dec 31, 2021 | -116.11% |
| Sep 30, 2021 | -138.96% |
| Jun 30, 2021 | -145.45% |